Our research

The main research product of Enthea so far is a cost-effectiveness analysis of drug liberalization as a mental health intervention.

We've taken a look at the potential of psychedelic therapy as an addiction treatment.

We have also prepared a summary & analysis of the full text of the Oregon 2020 ballot initiative to legalize therapeutic psilocybin.

Our research products:

• Report: psychedelics for addiction
• Oregon PSI 2020 ballot initiative – summary report
• Drug liberalization ballot initiative cost-effectiveness analysis
• [deprecated] Drug liberalization ballot initiative cost-effectiveness – minimum-benefit

And there's more research on our blog, including commentaries on recently published psychedelic papers!

Our summary of Carhart-Harris & Friston's REBUS paper is a reader favorite.